ArticleApplied microbiology and biotechnology2026
Redox-based dual-substrate fermentation enhances sustainable production of 3-hydroxypropionic acid by recombinant E. coli.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
3-Hydroxypropionic acid (3-HP) is an important platform chemical for a circular bioeconomy since it is a precursor for the production of several high-value derivatives such as acrylic acid as well as biodegradable plastics. Escherichia coli is a promising host for 3-HP biosynthesis due to its well-characterized metabolic network and ease of genetic manipulation. In E. coli, 3-HP is produced from glycerol via a two-step pathway involving glycerol dehydratase and an NAD⁺-dependent aldehyde dehydrogenase. However, a major limitation in this process is redox imbalance, as both glycerol catabolism and 3-HP biosynthesis generate excess NADH, thereby restricting NAD⁺ availability and limiting product formation. In this study, we systematically evaluated the influence of cosubstrate selection to enhance 3-HP production by decoupling biomass formation from product synthesis while achieving redox balance. An engineered E. coli strain, with knockouts of glycerol kinase (glpK) and glycerol dehydrogenase (gldA) to prevent glycerol catabolism, was employed to redirect glycerol flux exclusively toward 3-HP biosynthesis. A secondary carbon source was supplied to support cell growth and promote NAD⁺ regeneration. Six different sugars were evaluated as growth substrates to assess their impact on redox balance and 3-HP production. Among the tested secondary substrates, sucrose and xylose enabled high 3-HP titers of 61 and 50 g/L, respectively, significantly surpassing the 30 g/L titer obtained using glycerol as the sole carbon source. The strategy was successfully extended to renewable feedstocks such as molasses and pretreated lignocellulosic liquor hydrolysate in combination with crude glycerol, achieving 3-HP titers in the range of ~ 35-40 g/L. KEY POINTS: • Redox imbalance limits glycerol-based 3-HP biosynthesis in E. coli. • Redox-optimized dual-substrate feeding enhances 3-HP titer, yield and productivity. • Validation with renewable substrates provides feasibility for a circular bioeconomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.